Healthcare
The reimbursement, regulatory and technological environments in the healthcare sector are constantly evolving. Concurrently, demand for effective and affordable solutions is being driven primarily by the aging global population. At Canaccord Genuity, we are looking at exciting potential returns as quality innovation to serve a growing market is provided.
That is one of the reasons why we expanded our Healthcare and Life Sciences practice in 2015 with a team dedicated to high growth healthcare information technology companies. By combining our global resources and local expertise, we provide innovative thinking and ideas to help you navigate this dynamic sector.
As a leading independent global investment bank, we offer a wide range of advisory and capital raising services as well as complex cross-border expertise to both emerging and established companies. Our idea-driven M&A & Financial Advisory, Equity Capital Markets, Debt Advisory & Restructuring and Financial Sponsors services are tailored to helping our clients achieve their strategic and financial goals.
Our clients are public and private healthcare companies from across all sub sectors. We have in-depth expertise across the following:
- Biopharmaceuticals
- Cannabis
- Diagnostics
- HC Services
- HCITS
- Med Tech
Thomas O’Connor joins Canaccord Genuity
Canaccord Genuity Bolsters U.S. Healthcare Investment Banking Leadership.
Our Healthcare transactions
We have executed a number of deals over the last few years with a specific focus, in North America, on the MedTech and Diagnostics and Biopharma subsectors. See some of our recent transactions below:
More like this
Conisus
Meet our Healthcare team
We believe in developing and nurturing long term client partnerships. Our Healthcare sector team is keen to explore new opportunities and can offer our clients access to global capital markets due to our expertise across multiple regions. That means we can offer our clients highly relevant services. Please get in touch if you’d like to find out more.
US
Eugene Rozelman
Managing Director & Co-Head of Healthcare Investment Banking, Head of U.S. Biotech & Spec Pharma Investment Banking
Matt Steere
Managing Director & Co-Head Healthcare Investment Banking, Medical Technologies & Diagnostics
Asia
Australia
Canada
UK & Europe
Investment Banking
We have the independence and agility to offer clients sector-focused and idea-driven M&A Advisory, Equity Capital Markets, Debt Advisory and Restructuring and Financial Sponsors services.
Global locations
We have extensive operations in Asia, Australia, Canada, the Middle-East, the UK & Europe and the US.
Our events
Discover our upcoming events around the world.
Our analysts have in-depth knowledge and offer unique, informed insights that clients can access through our research portal.
Our sector coverage includes:
- Biomedical Devices and Services
- Biotechnology
- Cannabis
- Diagnostics and Tools
- Healthcare IT
- Healthcare Services
- Pharmaceuticals
- Veterinary Services
Sales & Trading
We provide access to global capital markets, connecting the right idea with the right client at the right time through our experienced team.
Corporate Access & Conferences
We have the contacts and expertise to help you find the right investors to speak to.
Quest®
Enjoy key investment insights from Quest®, our innovative online platform or get help, advice and support directly from our research and sales teams.
MiFID II
Our dedicated team ensured that all of our business areas that were affected by MiFID II / MiFIR were prepared for the 3rd of January.
How can we help?
If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.